Gemcitabine is a chemotherapy drug commonly used to treat various types of cancer, including pancreatic, lung, breast, and ovarian cancers. It works by interfering with the growth and spread of cancer cells in the body. Research on gemcitabine focuses on improving its efficacy, reducing side effects, and developing new combinations with other drugs or treatment modalities to enhance its anti-cancer effects. Studies also explore biomarkers and genetic factors that may predict a patient's response to gemcitabine and personalized treatment strategies. Overall, research in the area of gemcitabine aims to optimize its use in cancer therapy and improve outcomes for patients with different types of cancer.